Table 5. Example of Quality Assessment of Included Studies .
| Question | Wordsworth S, et al: 2001 |
Choi HCW et al, 2013 |
|
| 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract | Yes | Yes |
| 2 | (b) Provide in the abstract an informative and balanced summary of what was done and what was found | Yes | Yes |
| 3 | Explain the scientific background and rationale for the investigation being reported | Yes | Yes |
| 4 | State specific objectives, including any prespecified hypotheses | Yes | Yes |
| 5 | Present key elements of study design early in the paper | Yes | Yes |
| 6 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | Yes | Yes |
| 7 | (a) Give the eligibility criteria, and the sources and methods of selection of participants | Yes | Yes |
| 8 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | Yes | Yes |
| 9 | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | Yes | Yes |
| 10 | Describe any efforts to address potential sources of bias | No | No |
| 11 | Explain how the study size was arrived at | Yes | Yes |
| 12 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | Yes | Yes |
| 13 | (a) Describe all statistical methods, including those used to control for confounding | Yes | Yes |
| 14 | (b) Describe any methods used to examine subgroups and interactions | No | No |
| 15 | (c) Explain how missing data were addressed | No | Yes |
| 16 | (d) If applicable, describe analytical methods taking account of sampling strategy | Yes | Yes |
| 17 | (e) Describe any sensitivity analyses | No | No |
| 18 | (b) Give reasons for non-participation at each stage | No | No |
| 19 | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | Yes | Yes |
| 20 | (b) Indicate number of participants with missing data for each variable of interest | No | No |
| 21 | Report numbers of outcome events or summary measures | Yes | Yes |
| 22 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included | Yes | Yes |
| 23 | (b) Report category boundaries when continuous variables were categorized | Yes | Yes |
| 24 | Summarise key results with reference to study objectives | Yes | Yes |
| 25 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | Yes | Yes |
| 26 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | Yes | Yes |
| 27 | Discuss the generalisability (external validity) of the study results | Yes | Yes |
| 28 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | No | Yes |
| 29 | Does a detailed description of goods or services in question offered to the respondents? | No | Yes |
| 30 | Does the information and attributes expressed in goods or services scenarios is obtained from user or key informant assessments (e.g. focus groups, Delphi panels, interviews etc)? | No | Yes |
| 31 | Was there a pilot study conducted to assess the survey tool/design? | No | No |
| 32 | Does the survey involve face to face interviews? | No | No |
| 33 | Were those involved in data collection adequately trained? | No | NA |